Cargando…

The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes

OBJECTIVE: To evaluate the clinical value of glycosylated hemoglobin (HbA1c) in newly diagnosed ketosis-prone type 2 diabetes (KPD). METHODS: A total of 330 patients with newly diagnosed type 2 diabetes (T2DM) hospitalized in our department with an average age of 48.72 ± 13.07 years old were selecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Rui, Xu, Yancheng, Peng, Bocheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667908/
https://www.ncbi.nlm.nih.gov/pubmed/38027130
http://dx.doi.org/10.3389/fendo.2023.1244008
_version_ 1785139354256015360
author Min, Rui
Xu, Yancheng
Peng, Bocheng
author_facet Min, Rui
Xu, Yancheng
Peng, Bocheng
author_sort Min, Rui
collection PubMed
description OBJECTIVE: To evaluate the clinical value of glycosylated hemoglobin (HbA1c) in newly diagnosed ketosis-prone type 2 diabetes (KPD). METHODS: A total of 330 patients with newly diagnosed type 2 diabetes (T2DM) hospitalized in our department with an average age of 48.72 ± 13.07 years old were selected and divided into T2DM group (193 cases) and KPD group (137 cases) according to whether they were combined with ketosis. According to the quartile level of HbA1c, they were divided into group A (HbA1c < 8.90%, 84 cases), group B (8.90%≤HbA1c < 10.70%, 86 cases), group C (10.70%≤HbA1c ≤ 12.40%, 85 cases) and group D (HbA1c > 12.40%, 75 cases). The general clinical features, laboratory indicators and islet function of each group were compared. Spearman correlation analysis was used to explore the correlation between HbA1c and β- Hydroxybutyric acid (β- HB) and islet function. ROC curve was used to analyze the sensitivity and specificity of HbA1c in diagnosing KPD, and the optimal tangent point was obtained. RESULTS: HbA1c, β-HB, FFA, RBG, insulin dosage, GSP, OGTT (0, 0.5, 1, 2, 3h) in KPD group were significantly higher than those in T2DM group (P< 0.001). HDL-C, IRT (0, 0.5, 1, 2, 3h), HOMA-β, HOMA-IR, HOMA-IS, ΔC30/ΔG30, AUC (insulin) were significantly lower than those in T2DM group (P< 0.001). With the increase of HbA1c level, the incidence of ketosis, β-HB, FFA and insulin dosage increased, while IRT (0, 0.5, 1, 2, 3h), ΔC30/ΔG30, AUC (insulin), HOMA-β and HOMA-IS decreased accordingly (P< 0.001). In all newly diagnosed T2DM patients, Spearman correlation analysis showed that HbA1c was positively correlated with β-HB (r=0.539, P < 0.001), and was negatively correlated with HOMA-β (r=-0.564, P < 0.001), HOMA-IS (r=-0.517, P < 0.01, P < 0.001), HOMA-IR (r=-0.177, P < 0.001), ΔC30/ΔG30 (r=-0.427, P < 0.01) and AUC (insulin) (r=-0.581, P < 0.001). In ROC curve analysis, the optimal threshold for the diagnosis of KPD was 10.15%, Youden index was 0.616, area under the curve (AUC) was 0.882, sensitivity = 92.70%, specificity = 70.50%. CONCLUSION: In newly diagnosed T2DM patients, if HbA1c > 10.15%, it is more likely to develop KPD. Monitoring HbA1c level is conducive to timely detection of high-risk individuals with KPD and taking appropriate measures to prevent the occurrence and development of the disease.
format Online
Article
Text
id pubmed-10667908
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106679082023-01-01 The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes Min, Rui Xu, Yancheng Peng, Bocheng Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: To evaluate the clinical value of glycosylated hemoglobin (HbA1c) in newly diagnosed ketosis-prone type 2 diabetes (KPD). METHODS: A total of 330 patients with newly diagnosed type 2 diabetes (T2DM) hospitalized in our department with an average age of 48.72 ± 13.07 years old were selected and divided into T2DM group (193 cases) and KPD group (137 cases) according to whether they were combined with ketosis. According to the quartile level of HbA1c, they were divided into group A (HbA1c < 8.90%, 84 cases), group B (8.90%≤HbA1c < 10.70%, 86 cases), group C (10.70%≤HbA1c ≤ 12.40%, 85 cases) and group D (HbA1c > 12.40%, 75 cases). The general clinical features, laboratory indicators and islet function of each group were compared. Spearman correlation analysis was used to explore the correlation between HbA1c and β- Hydroxybutyric acid (β- HB) and islet function. ROC curve was used to analyze the sensitivity and specificity of HbA1c in diagnosing KPD, and the optimal tangent point was obtained. RESULTS: HbA1c, β-HB, FFA, RBG, insulin dosage, GSP, OGTT (0, 0.5, 1, 2, 3h) in KPD group were significantly higher than those in T2DM group (P< 0.001). HDL-C, IRT (0, 0.5, 1, 2, 3h), HOMA-β, HOMA-IR, HOMA-IS, ΔC30/ΔG30, AUC (insulin) were significantly lower than those in T2DM group (P< 0.001). With the increase of HbA1c level, the incidence of ketosis, β-HB, FFA and insulin dosage increased, while IRT (0, 0.5, 1, 2, 3h), ΔC30/ΔG30, AUC (insulin), HOMA-β and HOMA-IS decreased accordingly (P< 0.001). In all newly diagnosed T2DM patients, Spearman correlation analysis showed that HbA1c was positively correlated with β-HB (r=0.539, P < 0.001), and was negatively correlated with HOMA-β (r=-0.564, P < 0.001), HOMA-IS (r=-0.517, P < 0.01, P < 0.001), HOMA-IR (r=-0.177, P < 0.001), ΔC30/ΔG30 (r=-0.427, P < 0.01) and AUC (insulin) (r=-0.581, P < 0.001). In ROC curve analysis, the optimal threshold for the diagnosis of KPD was 10.15%, Youden index was 0.616, area under the curve (AUC) was 0.882, sensitivity = 92.70%, specificity = 70.50%. CONCLUSION: In newly diagnosed T2DM patients, if HbA1c > 10.15%, it is more likely to develop KPD. Monitoring HbA1c level is conducive to timely detection of high-risk individuals with KPD and taking appropriate measures to prevent the occurrence and development of the disease. Frontiers Media S.A. 2023-11-10 /pmc/articles/PMC10667908/ /pubmed/38027130 http://dx.doi.org/10.3389/fendo.2023.1244008 Text en Copyright © 2023 Min, Xu and Peng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Min, Rui
Xu, Yancheng
Peng, Bocheng
The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
title The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
title_full The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
title_fullStr The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
title_full_unstemmed The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
title_short The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
title_sort clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667908/
https://www.ncbi.nlm.nih.gov/pubmed/38027130
http://dx.doi.org/10.3389/fendo.2023.1244008
work_keys_str_mv AT minrui theclinicalvalueofglycosylatedhemoglobinlevelinnewlydiagnosedketosispronetype2diabetes
AT xuyancheng theclinicalvalueofglycosylatedhemoglobinlevelinnewlydiagnosedketosispronetype2diabetes
AT pengbocheng theclinicalvalueofglycosylatedhemoglobinlevelinnewlydiagnosedketosispronetype2diabetes
AT minrui clinicalvalueofglycosylatedhemoglobinlevelinnewlydiagnosedketosispronetype2diabetes
AT xuyancheng clinicalvalueofglycosylatedhemoglobinlevelinnewlydiagnosedketosispronetype2diabetes
AT pengbocheng clinicalvalueofglycosylatedhemoglobinlevelinnewlydiagnosedketosispronetype2diabetes